Jun Ho Lee1, Chang Sik Yu2, Jong Lyul Lee1, Chan Wook Kim1, Yong Sik Yoon1, In Ja Park1, Seok-Byung Lim1, Jin Cheon Kim1. 1. Division of Colon and Rectal Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. 2. Division of Colon and Rectal Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. csyu@amc.seoul.kr.
Abstract
PURPOSE: Data are lacking on the appropriate risk stratification of patients undergoing surgery for colorectal cancer (CRC). This study aimed to evaluate the predictive factors for perioperative morbidity and oncological outcomes in CRC patients with liver cirrhosis (LC). METHODS: A retrospective analysis of prospectively collected data was conducted. A total of 161 LC patients who underwent surgery for CRC were identified between January 2001 and December 2010. RESULTS: The mean patient age was 60 ± 10 years, and the median follow-up period was 54.0 months (range 0.5-170.0). The proportions of patients with Child-Pugh classifications for LC were as follows: A (n = 118; 73.3%), B (n = 39; 24.2%), and C (n = 4; 2.5%). The median model for end-stage liver disease (MELD) score was 8 (range 6-21). The postoperative morbidity rate was 37.3% (60/161). Hyperbilirubinemia (p = 0.002), prothrombin time (PT) prolongation (p = 0.020), and intraoperative transfusion (p = 0.003) were the significant factors for postoperative morbidity in multivariate analysis. The postoperative mortality rate was 3.1% (5/161), and the 5-year cancer-specific and 5-year overall survival rates were 86.1 and 59.9%, respectively. The significant clinical risk factors by multivariate analysis that influenced overall survival were the TNM stage of CRC (p = 0.035), MELD score (>8 points) (p < 0.001), and the coexistence of hepatocellular carcinoma (HCC) (p = 0.012). CONCLUSIONS: Hyperbilirubinemia, PT prolongation, and intraoperative transfusion are significant risk factors for postoperative morbidity in LC patients who undergo surgery for CRC. Additionally, not only advanced TNM stage but also a high MELD score and the coexistence of HCC are associated with poor overall survival in CRC patients with LC.
PURPOSE: Data are lacking on the appropriate risk stratification of patients undergoing surgery for colorectal cancer (CRC). This study aimed to evaluate the predictive factors for perioperative morbidity and oncological outcomes in CRC patients with liver cirrhosis (LC). METHODS: A retrospective analysis of prospectively collected data was conducted. A total of 161 LC patients who underwent surgery for CRC were identified between January 2001 and December 2010. RESULTS: The mean patient age was 60 ± 10 years, and the median follow-up period was 54.0 months (range 0.5-170.0). The proportions of patients with Child-Pugh classifications for LC were as follows: A (n = 118; 73.3%), B (n = 39; 24.2%), and C (n = 4; 2.5%). The median model for end-stage liver disease (MELD) score was 8 (range 6-21). The postoperative morbidity rate was 37.3% (60/161). Hyperbilirubinemia (p = 0.002), prothrombin time (PT) prolongation (p = 0.020), and intraoperative transfusion (p = 0.003) were the significant factors for postoperative morbidity in multivariate analysis. The postoperative mortality rate was 3.1% (5/161), and the 5-year cancer-specific and 5-year overall survival rates were 86.1 and 59.9%, respectively. The significant clinical risk factors by multivariate analysis that influenced overall survival were the TNM stage of CRC (p = 0.035), MELD score (>8 points) (p < 0.001), and the coexistence of hepatocellular carcinoma (HCC) (p = 0.012). CONCLUSIONS:Hyperbilirubinemia, PT prolongation, and intraoperative transfusion are significant risk factors for postoperative morbidity in LC patients who undergo surgery for CRC. Additionally, not only advanced TNM stage but also a high MELD score and the coexistence of HCC are associated with poor overall survival in CRC patients with LC.
Entities:
Keywords:
Colorectal cancer surgery; Liver cirrhosis; Perioperative morbidity; Perioperative mortality
Authors: Sang Hun Jung; Chang Sik Yu; Pyong Wha Choi; Dae Dong Kim; In Ja Park; Hee Cheol Kim; Jin Cheon Kim Journal: Dis Colon Rectum Date: 2008-04-12 Impact factor: 4.585
Authors: Felix Gundling; Holger Seidl; Fabian Schmidtler; Nicola Löffler; Ingrid Strassen; Petra Wolf; Christian Pehl; Thomas Schmidt; Wolfgang Schepp Journal: Anticancer Res Date: 2011-09 Impact factor: 2.480
Authors: Dana A Telem; Thomas Schiano; Robert Goldstone; Daniel K Han; Kerri E Buch; Edward H Chin; Scott Q Nguyen; Celia M Divino Journal: Clin Gastroenterol Hepatol Date: 2009-12-29 Impact factor: 11.382
Authors: Imke Honerkamp; Lisa Sandmann; Nicolas Richter; Michael P Manns; Torsten Voigtländer; Florian W R Vondran; Thomas von Hahn Journal: J Clin Exp Hepatol Date: 2021-04-02
Authors: Cornelius J van Beekum; Christina Beckmann; Alexander Semaan; Steffen Manekeller; Hanno Matthaei; Lara Braun; Maria A Willis; Jörg C Kalff; Tim O Vilz Journal: Front Med (Lausanne) Date: 2022-06-22
Authors: Hyun Gu Lee; Seok-Byung Lim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Jin Cheon Kim Journal: Sci Rep Date: 2022-09-01 Impact factor: 4.996